Literature DB >> 9250263

Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk.

M A Winkleby1, H A Feldman, D M Murray.   

Abstract

During the 1980s three comprehensive community-based heart disease prevention trials were conducted in the United States. The Stanford Five-City Project, Minnesota Heart Health Program, and Pawtucket Heart Health Program involved 12 cities; six received a 5-8 year multifactorial risk reduction program. This analysis pools data from the three studies to delineate the common intervention effects with greater sample size and power than could be attained by the single studies. Time trends were estimated for cigarette smoking, blood pressure, total cholesterol, body mass index, and coronary heart disease mortality risk in women and men aged 25-64 years. The joint estimates of intervention effect were in the expected direction in nine of 12 gender-specific comparisons; however, these were not statistically significant. The results illustrate the analytic challenges of evaluating community-based prevention trials and point to the smaller than expected net differences, rather than small sample size, as the reason for few statistically significant effects in the three U.S. prevention trials.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250263     DOI: 10.1016/s0895-4356(97)00020-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  22 in total

1.  The impact of a community-based heart disease prevention program in a low-income, inner-city neighborhood.

Authors:  J L O'Loughlin; G Paradis; K Gray-Donald; L Renaud
Journal:  Am J Public Health       Date:  1999-12       Impact factor: 9.308

2.  Using focus groups to develop a heart disease prevention program for ethnically diverse, low-income women.

Authors:  L Gettleman; M A Winkleby
Journal:  J Community Health       Date:  2000-12

Review 3.  Reconsidering community-based health promotion: promise, performance, and potential.

Authors:  Cheryl Merzel; Joanna D'Afflitti
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

4.  Impact of a two-city community cancer prevention intervention on African Americans.

Authors:  Daniel S Blumenthal; Jane G Fort; Nasar U Ahmed; Kofi A Semenya; George B Schreiber; Shelley Perry; Joyce Guillory
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 5.  Role of community programs in controlling blood pressure.

Authors:  Robinson Fulwood; Jeanette Guyton-Krishnan; Madeleine Wallace; Ellen Sommer
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

6.  Contribution of neighbourhood socioeconomic status and physical activity resources to physical activity among women.

Authors:  Rebecca E Lee; Catherine Cubbin; Marilyn Winkleby
Journal:  J Epidemiol Community Health       Date:  2007-10       Impact factor: 3.710

7.  Building the backbone for organisational research in public health systems: development of measures of organisational capacity for chronic disease prevention.

Authors:  Nancy Hanusaik; Jennifer L O'Loughlin; Natalie Kishchuk; John Eyles; Kerry Robinson; Roy Cameron
Journal:  J Epidemiol Community Health       Date:  2007-08       Impact factor: 3.710

8.  Improving health behaviors in an African American community: the Charlotte Racial and Ethnic Approaches to Community Health project.

Authors:  Marcus Plescia; Harry Herrick; LaTonya Chavis
Journal:  Am J Public Health       Date:  2008-07-16       Impact factor: 9.308

9.  Community based heart health promotion project in England. Self reporting overestimates smoking cessation rates.

Authors:  J Muir; T Lancaster; G Fowler; A Neil
Journal:  BMJ       Date:  1998-02-28

10.  Effect of cross-level interaction between individual and neighborhood socioeconomic status on adult mortality rates.

Authors:  Marilyn Winkleby; Catherine Cubbin; David Ahn
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.